This brand name is authorized in France
The drug ESTROTEP contains one active pharmaceutical ingredient (API):
|
1
Fluoroestradiol ¹⁸F
UNII T32277KB09 - FLUOROESTRADIOL F-18
|
|
Fluoroestradiol ¹⁸F binds estrogen receptor (ER) and is indicated for use with positron emission tomography (PET imaging) for characterization of ER status of known or suspected metastatic lesions in patients with confirmed ER-positive breast cancer. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09IX11 | V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 64307631 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
